SEC Form 4 · accession 0001624073-16-000006

Syneos Health, Inc. · SYNH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Alistair Macdonald

Officer — Chief Operating Officer

Period of report

Dec 31, 2015

Accepted (ET)

Jan 4, 2016 · 4:00 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001610950

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Dec 31, 2015	S	46,982	$48.64	D	8,699	D
Class A Common Stock	Dec 31, 2015	M	31,241	$8.45	A	39,940	D
Class A Common Stock^F2	Dec 31, 2015	S	20,366	$46.64	D	19,574	D
Class A Common Stock^F3	Dec 31, 2015	S	10,427	$47.54	D	9,147	D
Class A Common Stock	Dec 31, 2015	S	448	$48.64	D	8,699	D
Class A Common Stock	Dec 31, 2015	M	52,972	$10.57	A	61,671	D
Class A Common Stock^F4	Dec 31, 2015	S	34,521	$46.64	D	27,150	D
Class A Common Stock^F3	Dec 31, 2015	S	17,690	$47.54	D	9,460	D
Class A Common Stock	Dec 31, 2015	S	761	$48.64	D	8,699	D
Class A Common Stock	Dec 31, 2015	M	28,404	$16.06	A	37,103	D
Class A Common Stock^F4	Dec 31, 2015	S	18,513	$46.64	D	18,590	D
Class A Common Stock^F3	Dec 31, 2015	S	9,483	$47.54	D	9,107	D
Class A Common Stock	Dec 31, 2015	S	408	$48.64	D	8,699	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F5	$8.45	Dec 31, 2015	M	31,241	D	—	Sep 28, 2020	Class A Common Stock	31,241	29,680	D
Stock Option (Right to Buy Class A Common Stock)^F6	$10.57	Dec 31, 2015	M	52,972	D	—	Aug 17, 2022	Class A Common Stock	52,972	35,312	D
Stock Option (Right to Buy Class A Common Stock)^F7	$16.06	Dec 31, 2015	M	28,404	D	—	Jun 30, 2024	Class A Common Stock	28,404	66,270	D

Explanation of responses

F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b-1 trading plan adopted by the reporting person on November 4, 2015.
F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.31 to $47.01, inclusive. The reporting person will provide to the INC Research Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $47.47 to $48.07, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.31 to $47.01, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5One half of the shares subject to this option vest yearly in five equal installments beginning on September 28, 2011, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.
F6One half of the shares subject to this option vest yearly in five equal installments beginning on August 17, 2013, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.
F7One half of the shares subject to this option vest yearly in five equal installments beginning on June 30, 2015, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2014, subject to continued employment.